Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2025-01-042025-01-042020-04-16https://hdl.handle.net/11288/597996enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/COVID-19PharmacyPandemicsDrug therapyRemdesivir for COVID-19: Evidence review of the clinical benefit and harmTechnical Report